[HTML][HTML] Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection

AR Rappaport, SJ Hong, CD Scallan, L Gitlin… - Nature …, 2022 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic continues to spread globally,
highlighting the urgent need for safe and effective vaccines that could be rapidly mobilized …

Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection

AR Rappaport, SJ Hong, CD Scallan, L Gitlin… - Nature …, 2022 - ideas.repec.org
The coronavirus disease 2019 (COVID-19) pandemic continues to spread globally,
highlighting the urgent need for safe and effective vaccines that could be rapidly mobilized …

[PDF][PDF] Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection

AR Rappaport, SJ Hong, CD Scallan, L Gitlin… - d-nb.info
Results SAM and ChAd vaccines encoding full-length SARS-CoV-2 spike were evaluated
for immunogenicity in mice. Serum was collected at various timepoints post a single …

Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection

AR Rappaport, SJ Hong, CD Scallan… - Nature …, 2022 - econpapers.repec.org
Abstract The coronavirus disease 2019 (COVID-19) pandemic continues to spread globally,
highlighting the urgent need for safe and effective vaccines that could be rapidly mobilized …

Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection.

AR Rappaport, SJ Hong, CD Scallan… - Nature …, 2022 - search.ebscohost.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic continues to spread globally,
highlighting the urgent need for safe and effective vaccines that could be rapidly mobilized …

Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection

AR Rappaport, SJ Hong, CD Scallan… - Nature …, 2022 - ui.adsabs.harvard.edu
Abstract The coronavirus disease 2019 (COVID-19) pandemic continues to spread globally,
highlighting the urgent need for safe and effective vaccines that could be rapidly mobilized …

[HTML][HTML] Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection

AR Rappaport, SJ Hong, CD Scallan, L Gitlin… - Nature …, 2022 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) pandemic continues to spread globally,
highlighting the urgent need for safe and effective vaccines that could be rapidly mobilized …

Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection.

AR Rappaport, SJ Hong, CD Scallan, L Gitlin… - Nature …, 2022 - europepmc.org
Abstract The coronavirus disease 2019 (COVID-19) pandemic continues to spread globally,
highlighting the urgent need for safe and effective vaccines that could be rapidly mobilized …

Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection

AR Rappaport, SJ Hong, CD Scallan… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
The coronavirus disease 2019 (COVID-19) pandemic continues to spread globally,
highlighting the urgent need for safe and effective vaccines that could be rapidly mobilized …

Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection.

AR Rappaport, SJ Hong, CD Scallan, L Gitlin… - Nature …, 2022 - europepmc.org
Abstract The coronavirus disease 2019 (COVID-19) pandemic continues to spread globally,
highlighting the urgent need for safe and effective vaccines that could be rapidly mobilized …